Aspects of growth hormone control in diabetes.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Australian and New Zealand journal of ophthamology (Print)

• Publication date

  1990-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1442-9071.1990.TB00582.XPMID 2113400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth hormone and endothelial function during exercise in diabetics with and without retinopathy.

  2009cited by this paper
• Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathy.

  1989cited by this paper
• Failure to suppress GH secretion after 2 weeks treatment with atropine or propanthelene in diabetics with proliferative retinopathy.

  1988cited by this paper
• Serum IGF‐1 Concentration in Diabetic Retinopathy

  1988cited by this paper
• Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.

  1988cited by this paper
• Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy

  1987cited by this paper
• CHOLINERGIC MUSCARINIC RECEPTOR BLOCKADE WITH PIRENZEPINE ABOLISHES SLOW WAVE SLEEP‐RELATED GROWTH HORMONE RELEASE IN YOUNG PATIENTS WITH INSULIN‐DEPENDENT DIABETES MELLITUS

  1987cited by this paper
• Pirenzepine Blunts the Nocturnal Growth Hormone Release in Insulin Dependent Diabetes

  1987cited by this paper
• GROWTH HORMONE PRETREATMENT IN MAN BLOCKS THE RESPONSE TO GROWTH HORMONE‐RELEASING HORMONE; EVIDENCE FOR A DIRECT EFFECT OF GROWTH HORMONE

  1987cited by this paper
• Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration.

  1986cited by this paper
• ATROPINE SELECTIVELY BLOCKS GHRH‐INDUCED GH SECRETION WITHOUT ALTERING LH, FSH, TSH, PRL AND ACTH/CORTISOL SECRETION ELICITED BY THEIR SPECIFIC HYPOTHALAMIC RELEASING FACTORS

  1986cited by this paper
• Effect of propantheline on growth hormone and blood glucose levels.

  1986cited by this paper
• Paracrine functions of somatomedins.

  1986cited by this paper
• Nutrition, somatomedins, and the brain.

  1986cited by this paper
• Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels.

  1986cited by this paper
• Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in acromegaly and type I diabetes mellitus.

  1986cited by this paper
• Prolonged secretion of prolactin in response to thyrotrophin-releasing hormone after hypothalamo-pituitary disconnection in the ewe.

  1986cited by this paper
• Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age.

  1986cited by this paper
• 3 Paracrine functions of somatomedins

  1986cited by this paper
• Impaired Somatomedin Generation Test in Children with Insulin-dependent Diabetes Mellitus

  1985cited by this paper
• Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin.

  1985cited by this paper
• THE EFFECTS OF CHOLINERGIC BLOCKADE ON THE GROWTH HORMONE AND PROLACTIN RESPONSE TO INSULIN HYPOGLYCAEMIA

  1985cited by this paper
• Growth Hormone Responses to Growth-Hormone-Releasing Hormone and Thyrotropin-Releasing Hormone in Diabetic Patients With and Without Retinopathy

  1985cited by this paper
• Growth Hormone Response to Hyperinsulinaemia in Insulin‐dependent Diabetics Comparison of Patients With and Without Retinopathy

  1984cited by this paper
• Development of diabetic complications despite the absence of growth hormone in a patient with post-pancreatectomy diabetes.

  1984cited by this paper
• Role of growth hormone in diabetes mellitus.

  1984cited by this paper
• Evidence for a Central Abnormality in the Regulation of Growth Hormone Secretion in Insulin‐dependent Diabetes

  1984cited by this paper
• Effect of Diabetes and its Control on Insulin-like Growth Factors in the Young Subject with Type I Diabetes

  1984cited by this paper
• Von Willebrand Factor (VIII R: Ag), Fibronectin, and Insulin-like Growth Factors I and II in Diabetic Retinopathy and Nephropathy

  1984cited by this paper
• Pituitary Response to Growth Hormone–releasing Factor in Diabetes: Failure of Glucose-mediated Suppression

  1984cited by this paper
• Insulin-like growth factors. Studies in diabetics with and without retinopathy.

  1983cited by this paper
• Effects of propantheline bromide on basal growth hormone, cortisol and prolactin levels.

  1983cited by this paper
• Effect of Pubertal Stage and Recent Blood Glucose Control on Plasma Somatomedin C in Children with Insulin-dependent Diabetes Mellitus

  1981cited by this paper
• Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary.

  1981cited by this paper
• Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders.

  1980cited by this paper
• Association between Serum Insulin, Serum Somatomedin and Liver Receptors for Human Growth Hormone in Streptozotocin Diabetes

  1980cited by this paper
• Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality.

  1980cited by this paper
• Integrated Concentration of Growth Hormone in Juvenile-onset Diabetes

  1980cited by this paper
• STIMULATION BY GROWTH HORMONE OF SOMATOSTATIN RELEASE FROM THE RAT HYPOTHALAMUS IN VITRO

  1978cited by this paper
• A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes.

  1978cited by this paper
• C3 IN CYSTIC FIBROSIS

  1975cited by this paper
• Hypophysectomy in Diabetic Retinopathy: The Relationship Between the Degree of Pituitary Ablation and Ocular Response

  1974cited by this paper
• Influence of muscular exercise on plasma level of growth hormone in diabetics with and without retinopathy.

  1974cited by this paper
• Abnormal Serum Growth Hormone Response to Exercise in Maturity-onset Diabetics

  1973cited by this paper
• Tactile manual agnosia.

  1972cited by this paper
• Serum growth hormone patterns in juvenile diabetes.

  1972cited by this paper
• Serum growth hormone patterns in juvenile diabetes.

  1972cited by this paper
• Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics

  1970cited by this paper
• Cholinergic Blockade and Growth Hormone Responsiveness to Insulin Hypoglycemia∗

  1969cited by this paper
• Serum Growth Hormone Levels and the Response of Diabetic Retinopathy to Pituitary Ablation*

  1969cited by this paper
• Growth hormone secretion in response to arginine infusion in normal and diabetic subjects: relationship to blood glucose levels.

  1968cited by this paper
• The Houssay Phenomenon in Man: Recovery from Retinopathy in a Case of Diabetes With Simmonds' Disease

  1953cited by this paper
• Poliomyelitis and tonsillectomy.

  1948cited by this paper
• Introductory Remarks Delivered at the Opening of the Section of Ophthalmology

  1900cited by this paper

• Growth hormone and ocular dysfunction: Endocrine, paracrine or autocrine etiologies?

  2016cites this paper
• Cuantificación de eritropoyetina y somatostatina intravítrea: estudio comparativo entre pacientes con diabetes mellitus y trombosis venosa retiniana

  2008cites this paper
• Deterioration of diabetic retinopathy during growth hormone therapy in a pan‐hypopituitary diabetic patient

  2008cites this paper
• Use of long-acting somatostatin analogue treatment in diabetic retinopathy.

  2007cites this paper
• Pharmacokinetics, Pharmacodynamics, and Safety of Microencapsulated Octreotide Acetate in Healthy Subjects

  2000cites this paper